SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (582)10/5/2001 1:02:49 AM
From: scaram(o)uche  Read Replies (2) of 1833
 
Closing market cap today was $11.2 million. After the Arena deal (what does a "binding" letter of agreement mean with respect to the cash that changed hands, given that we haven't heard of a final deal?), BulbaMan came up with a post-money valuation of about $7 million for the KDUS share of Axiom. Since then, Biacore did the $5 million deal, $2 million to the coffers and $3 million that Axiom used to repurchase 75% of the shares owned by Biacore.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext